Isolated focal cortical dysplasia type Ia

Isolated focal cortical dysplasia type Ia (FCD type Ia) is a rare malformation of cortical development characterized by abnormal radial columnar organization (dyslamination) of the cerebral cortex without associated abnormalities such as tumors, vascular malformations, or other brain lesions. It belongs to the broader group of focal cortical dysplasias, which are among the most common causes of drug-resistant (medically refractory) epilepsy, particularly in children. In FCD type Ia, the normal six-layered architecture of the neocortex is disrupted, with abnormal vertical microcolumnar arrangements of neurons. This subtype is classified under the International League Against Epilepsy (ILAE) classification system. The primary clinical manifestation of isolated FCD type Ia is epilepsy, which often presents in childhood and may be resistant to antiepileptic medications. Seizure types vary depending on the location of the dysplastic cortex and can include focal seizures with or without impairment of awareness, and secondary generalized seizures. Patients may also experience developmental delay, cognitive impairment, or neurological deficits depending on the extent and location of the malformation. Diagnosis is supported by brain MRI, though FCD type Ia can be subtle or even undetectable on standard neuroimaging, and definitive diagnosis often requires histopathological examination of surgically resected tissue. The treatment landscape centers on seizure management. First-line therapy involves antiepileptic drugs, but many patients with FCD type Ia have drug-resistant epilepsy. For these individuals, surgical resection of the dysplastic cortex is the primary treatment option and can lead to significant seizure reduction or seizure freedom in selected cases. However, surgical outcomes for FCD type Ia tend to be less favorable compared to other FCD subtypes (such as type IIb), partly due to the difficulty in precisely delineating the lesion boundaries. Presurgical evaluation typically involves video-EEG monitoring, advanced neuroimaging, and sometimes invasive intracranial electrode monitoring to localize the epileptogenic zone.

Common questions about Isolated focal cortical dysplasia type Ia